Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Spinal Cord Stimulation Devices Market, by Product
1.4.2 North America Spinal Cord Stimulation Devices Market, by Application
1.4.3 North America Spinal Cord Stimulation Devices Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. North America Spinal Cord Stimulation Devices Market by Applications
3.1 North America Complex Regional Pain Syndrome Market by Country
3.2 North America Unsuccessful Disk Surgery Market by Country
3.3 North America Failed Back Syndrome Market by Country
3.4 North America Degenerative Disk Disease Market by Country
3.5 North America Other Applications Market by Country
Chapter 4. North America Spinal Cord Stimulation Devices Market by Product
4.1 North America Rechargeable Market by Country
4.2 North America Non-Rechargeable Market by Country
Chapter 5. North America Spinal Cord Stimulation Devices Market by Country
5.1 USA Spinal Cord Stimulation Devices Market
5.1.1 USA Spinal Cord Stimulation Devices Market by Applications
5.1.2 USA Spinal Cord Stimulation Devices Market by Product
5.2 Canada Spinal Cord Stimulation Devices Market
5.2.1 Canada Spinal Cord Stimulation Devices Market by Applications
5.2.2 Canada Spinal Cord Stimulation Devices Market by Product
5.3 Mexico Spinal Cord Stimulation Devices Market
5.3.1 Mexico Spinal Cord Stimulation Devices Market by Applications
5.3.2 Mexico Spinal Cord Stimulation Devices Market by Product
5.4 Rest of North America Spinal Cord Stimulation Devices Market
5.4.1 Rest of North America Spinal Cord Stimulation Devices Market by Applications
5.4.2 Rest of North America Spinal Cord Stimulation Devices Market by Product
Chapter 6. Company Profiles
6.1 Boston Scientific Corporation
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expense
6.1.1 Recent strategies and developments:
6.1.1.1 Product launches:
6.1.1.2 Acquisition and mergers:
6.1.1.3 Collaborations, partnerships and agreements:
6.2 Medtronic PLC
6.2.1 Company overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expenses
6.2.5 Recent strategies and developments:
6.2.5.1 Product launches:
6.2.5.2 Approvals:
6.3 Abbott Laboratories (St. Jude Medical, Inc.)
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental and Regional Analysis
6.3.4 Research & Development Expense
6.3.5 Recent strategies and developments:
6.3.5.1 Product launches:
6.3.5.2 Collaborations, partnerships and agreements:
6.3.5.3 Acquisition and mergers:
6.4 Neurosigma, Inc.
6.4.1 Company Overview
6.5 Nevro Corporation
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Regional Analysis
6.5.4 Research & Development Expense
6.5.5 Recent strategies and developments:
6.5.5.1 Approvals:
6.6 Synapse BioMedical, Inc.
6.6.1 Company Overview
6.6.2 Recent strategies and developments:
6.6.2.1 Collaborations, partnerships and agreements:
6.7 Integer Holdings Corporation
6.7.1 Company Overview
6.7.2 Financial Analysis
6.7.3 Segmental and Regional Analysis
6.7.4 Research & Development Expense
6.8 Stimwave Technologies, Inc.
6.8.1 Company Overview
6.8.2 Recent strategies and developments:
6.8.2.1 Approvals:
6.9 Nuvectra Corporation
6.9.1 Company Overview
6.9.2 Financial Analysis
6.9.3 Regional Analysis
6.9.4 Research & Development Expense
6.9.5 Recent strategies and developments:
6.9.5.1 Approvals:
6.1 Saluda Medical Pty Ltd.
6.10.1 Company Overview
6.10.2 Recent strategies and developments:
6.10.2.1 Product launches:
Unique Offerings 